 Connection
Adnin Zaman to Hypoglycemic Agents
This is a "connection" page, showing publications Adnin Zaman has written about Hypoglycemic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.144 |
|
|
|
-
Yu Y, Li X, Groth SW, Zaman A, Chao AM, Phelan S, Hollenbach SJ, Dreisbach C. Gestational Weight Gain and Pregnancy Outcomes After Semaglutide Exposure. Obstet Gynecol. 2026 Aug 01; 148(2):229-237.
Score: 0.120
-
Chan LE, Casiraghi E, Laraway B, Coleman B, Blau H, Zaman A, Harris NL, Wilkins K, Antony B, Gargano M, Valentini G, Sahner D, Haendel M, Robinson PN, Bramante C, Reese J. Metformin is associated with reduced COVID-19 severity in patients with prediabetes. Diabetes Res Clin Pract. 2022 Dec; 194:110157.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|